A
blood cell analyzer
diluent and a hemolytic agent, are characterized in that one litre
diluent is provided with 12.0-4.0g of
sodium chloride, 2.0-10.0g of
sodium sulfate, 0.8-0.5g of 1,3,2-methylol
urea, 0.2-0.5g of
copper sulfite, 3.0-8.0g of EDTA-2Na, 0.2-0.7g of
Piperacillin Sodium, a borate buffering liquid toning the ph value to 7.2-7.8, and the balance is water; one litre hemolytic agent is provided with 0.8-5.0g of
potassium chloride, 0-60.0g of dodecyl trimethyl
ammonium chloride, 14.0-0g of octadecyl trimethyl
ammonium bromide, 6.0-10.0ml of isopropanol,
carbonate or alcaine buffering liquid toning the ph value to 7.2-7.8, and the balance is water. The inventive
reagent can form stable
hemoglobin derivatives, and the absorption spectrum curves are similar when lambada is 540nm, lambada is 504nm, which can satisfy the clinical inspection requirement; the
reagent does not contain
cyanide,
azide, and has non-
toxicity, which can effective improve working
atmosphere of operating staff, and can reduce harm of
toxicant to personal health.